GSK.L GSK PLC ORD 31 1/4P | GB00BN7SWP63
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 35.652.379.320 | 33.903.381.380 | 5.16% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 1,95 | 1,79 | 8.89% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 16 | 16 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |